(Q34221114)

31 July 2017

Treating substance abuse in schizophrenia. An initial report (English)

1 reference

31 July 2017

0 references

1 reference

Bennett ME

1

1 reference

PubMed ID

11306219

31 July 2017

Bellack AS

series ordinal

2

1 reference

PubMed ID

11306219

31 July 2017

Gearon JS

series ordinal

3

1 reference

31 July 2017

1 March 2001

1 reference

Journal of Substance Abuse Treatment

31 July 2017

1 reference

31 July 2017

20

1 reference

31 July 2017

2

1 reference

31 July 2017

163-175

1 reference

Effects of illicit drug use in an inpatient psychiatric population.

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Treating substance abuse among patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Substance abuse treatment for people with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Social problem solving in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Substance use reduction in the context of outpatient psychiatric treatment: a collaborative, motivational, harm reduction approach

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Risk for human immunodeficiency virus (HIV) infection among persons with severe mental illnesses

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Treatment of negative symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Alcohol use and abuse in schizophrenia. A prospective community study

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

The course, treatment, and outcome of substance disorder in persons with severe mental illness

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Review of integrated mental health and substance abuse treatment for patients with dual disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Drug-use behavior and correlates in people with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

HIV/AIDS risks as a consequence of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Alcoholism followed by schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Correlates of suicide attempts and ideation in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Cannabis abuse and the course of recent-onset schizophrenic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

The Fifth Edition of the Addiction Severity Index

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Prediction of compliance with outpatient referral in patients with schizophrenia and psychoactive substance use disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Social functioning of schizophrenic patients: clinical and research issues

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

In search of how people change. Applications to addictive behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Analysis of three interventions for substance abuse treatment of severely mentally ill people.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Decisional balance measure for assessing and predicting smoking status

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model.

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

Comorbidity of schizophrenia and substance abuse: implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0740-5472%2800%2900167-7

7 January 2021

10.1016/S0740-5472(00)00167-7

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11306219